How many patents does
Ardea Biosciences have?
patents
901
families
50
granted
214
applications
687
US
144
EP
91
CN
51
WO
47
JP
33
KR
25
RoW
510
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Ardea Biosciences
Top ten assignees appearing on patents
2009 - 2018
2009
| ardea biosciences | 51 |
| andrea biosciences | 1 |
2018
| ardea biosciences | 49 |
| astrazeneca | 8 |
| bayer intellectual property | 1 |
Ardea Biosciences
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| thioacetate compounds, compositions and methods of use | 86 | 2010 |
| s-triazolyl alpha-mercaptoacetanildes as inhibitors of hiv reverse transcriptase | 69 | 2004 |
| novel compounds and compositions and methods of use | 67 | 2007 |
| compounds, compositions and methods of using same for modulating uric acid levels | 56 | 2008 |
| preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyph… 🛈 | 49 | 2009 |
| derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as w… 🛈 | 46 | 2005 |
| polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylth… 🛈 | 44 | 2010 |
| manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)ace… 🛈 | 37 | 2012 |
| chiral synthesis of n-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-… 🛈 | 35 | 2011 |
| pharmaceutical combinations comprising rdea119/bay 869766 for the treatment of specific … 🛈 | 33 | 2009 |